Brookline, MA, United States of America

Anna Irmina Markowska

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Ymir Genomics, LLC. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anna Irmina Markowska. Retrieved from https://idiyas.com/inventor/anna-irmina-markowska

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

Average Co-Inventor Count = 4.3

ph-index = 1


Company Filing History:


Years Active: 2016-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Anna Irmina Markowska

Introduction

Anna Irmina Markowska is a prominent inventor based in Brookline, MA (US). She has made significant strides in the field of bioparticle research, holding a total of 3 patents. Her work focuses on the development of non-toxic materials and methods for isolating bioparticles, which have important implications for diagnostics and therapeutics.

Latest Patents

Markowska's latest patents include innovative compositions and methods aimed at reducing bioparticle levels in organisms. One of her notable inventions involves the application of non-toxic bioparticle absorbing materials, specifically designed for prophylactic and therapeutic purposes. Additionally, she has developed methods for isolating extracellular vesicles and other bioparticles from urine and other biofluids. These methods facilitate the purification and concentration of biological molecules that serve as diagnostic or prognostic biomarkers. Furthermore, her work includes techniques for producing biofluids that are largely depleted of bioparticles, enhancing their utility in experimental systems.

Career Highlights

Anna Irmina Markowska is currently associated with Ymir Genomics, LLC, where she continues to advance her research in bioparticle isolation and application. Her contributions to the field have been recognized for their potential to improve diagnostic processes and therapeutic strategies.

Collaborations

Markowska collaborates with notable colleagues, including Patrick Shannon Pendergrast and Robert Scott Pendergrast. Their combined expertise enhances the innovative research being conducted at Ymir Genomics, LLC.

Conclusion

Anna Irmina Markowska's work exemplifies the impact of innovative research in the field of bioparticles. Her patents and ongoing contributions are paving the way for advancements in diagnostics and therapeutics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…